FindTrial
Sign In

To rule out the effect of Vasaghrita in Urdhvag Amlapitta(Hyperacidity)according to Chakradatta

Study of Trisutra in Urdhvag Amlapitta and its management by Vasaghrita w.s.r. to Chakradatta

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037529
Enrollment
60
Registered
2021-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

Mahatma Gandhi Ayurved College Hospital Research Centre Salod H Wardha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient age above 20 yrs. and below 65 yrs. 2 both sexes will be selected. 3 Patient suffering from typical signs and symptoms of Amlapitta

Exclusion criteria

Exclusion criteria: 1 Patient age group below 20 yrs. and above 65 yrs. were excluded. 2 Pregnant and lactating mother. 3 Patients suffering from chronic diseases such as diabetes, hypertension, IHD, chemotherapy and major operative procedure etc., were excluded. 4 Irregular patients not providing proper data were excluded.

Design outcomes

Primary

MeasureTime frame
Effect of Vasaghrita in Urdhvag AmlapittaTimepoint: 2 weeks—

Secondary

MeasureTime frame
Effect of Vasaghrita in Urdhvag Amlapitta in all types of ParametersTimepoint: 2 weeks—

Countries

India

Contacts

Public ContactDr Preeti Borker

Mahatma Gandhi Ayurved College Hospital & Research Centre Salod (H) Wardha

preetiborkar1977@gmail.com8446127058

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026